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Identity 
Other names: TRAP-1; TRAP1 




Encoded on the minus strand. 12 exons, exon number 1 
is not depicted in the diagram and appears to undergo 
differential splicing, according to recent NCBI-
AceView (accessed 17 Apr 2011). 
Transcription 
Work by the Wurthner lab in 2003-2005 identified an 
860 aa protein that could be matched with genomic 
sequences. Recently predicted proteins from mRNA 
variants describe translation products of 896, 952, 161 




A fragment of TGFBRAP1 was initially identified in a 
Yeast-2-Hybrid screen as a TGF-beta type I receptor 
interacting protein (Charng et al., 2002). Further work 
by Wurthner et al. demonstrated binding of the full-
length molecule exclusively to either TGF-beta 
receptor I and TGF-beta receptor II, or to Smad4, 
suggesting TGFBRAP1 to be a Smad4 chaperone 
(Wurthner et al., 2001). Furthermore, receptor activated 
Smads were shown to compete for binding of TRAP1 
with Smad4, suggesting only a transient association 
between TRAP1 and Smad4. In addition, an interaction 
of TRAP1 with 5-lipoxgenase in a yeast two-hybrid 
system was described by a different group (Provost et 
al., 1999). Gene inactivation of TGFBRAP1 through 
conventional targeting leads to early developmental 
arrest of murine embryos around day E 6.5 (Messler et 
al., 2010). 
 
Generated by BlastAnalyser in 2005 (unpublished). Contig: NT_022171.13 (gi: 29789878). 
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Punctate pattern suggestive of endosomal localisation. 
Function 
Chaperone for Smad4 in the TGF-beta signal 
transduction cascade (Wurthner et al., 2001). 
Endosomal trafficking (circumstantial evidence: 
domain structure and early embryonic lethality; 
Messler et al., 2010). 
Homology 
hVPS39 (hVam6, hTrap-like-Protein). 
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